DK1713805T3 - Kinaseinhibitorer - Google Patents

Kinaseinhibitorer

Info

Publication number: DK1713805T3
Authority: DK; Denmark
Prior art keywords: kinase inhibitors; kinase; inhibitors
Prior art date: 2004-01-30

Application number

DK05704878T

Other languages

English (en)

Inventor

Rosanne Bonjouklian

Chafiq Hamdouchi

Chuan Shih

Dios Alfonso De

Prado Miriam Filadelfa Del

Aguado Carlos Jaramillo

Pramila Kotiyan

Mary Margaret Mader

Sheila Pleite Selgas

Concepcion Sanchez-Martinez

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-30

Filing date

2005-01-25

Publication date

2009-08-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34837430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1713805(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-01-25 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2009-08-17 Application granted granted Critical

2009-08-17 Publication of DK1713805T3 publication Critical patent/DK1713805T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK05704878T 2004-01-30 2005-01-25 Kinaseinhibitorer DK1713805T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US54083004P	2004-01-30	2004-01-30
PCT/US2005/000025 WO2005075478A1 (en)	2004-01-30	2005-01-25	Kinase inhibitors

Publications (1)

Publication Number	Publication Date
DK1713805T3 true DK1713805T3 (da)	2009-08-17

Family

ID=34837430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05704878T DK1713805T3 (da)	2004-01-30	2005-01-25	Kinaseinhibitorer

Country Status (26)

Country	Link
US (2)	US7582652B2 (da)
EP (1)	EP1713805B1 (da)
CN (1)	CN100516064C (da)
AR (1)	AR047466A1 (da)
AT (1)	ATE433449T1 (da)
AU (1)	AU2005210459B2 (da)
CA (1)	CA2559128C (da)
CY (1)	CY1109234T1 (da)
DE (1)	DE602005014848D1 (da)
DK (1)	DK1713805T3 (da)
DO (1)	DOP2005000010A (da)
ES (1)	ES2326819T3 (da)
HK (1)	HK1100141A1 (da)
IL (1)	IL178103A (da)
MY (1)	MY143516A (da)
NZ (1)	NZ549780A (da)
PE (1)	PE20050689A1 (da)
PL (1)	PL1713805T3 (da)
PT (1)	PT1713805E (da)
RU (1)	RU2348635C2 (da)
SI (1)	SI1713805T1 (da)
SV (1)	SV2006002001A (da)
TW (1)	TWI332003B (da)
UA (1)	UA85505C2 (da)
WO (1)	WO2005075478A1 (da)
ZA (1)	ZA200607648B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI332003B (en) *	2004-01-30	2010-10-21	Lilly Co Eli	Kinase inhibitors
US7776869B2 (en) *	2004-10-18	2010-08-17	Amgen Inc.	Heteroaryl-substituted alkyne compounds and method of use
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
DK2571878T3 (da) *	2010-05-17	2019-02-11	Indian Incozen Therapeutics Pvt Ltd	Hidtil ukendte 3,5-disubstituerede-3h-imidazo[4,5-b]pyridin- og 3,5- disubstituerede -3h-[1,2,3]triazol[4,5-b]pyridinforbindelser som modulatorer af proteinkinaser
AR083868A1 (es) *	2010-12-03	2013-03-27	Lilly Co Eli	Compuestos de oxazol[5,4-b]piridin-5-ilo
HUE037928T2 (hu) *	2011-11-11	2018-09-28	Lilly Co Eli	Kombinációs terápia petefészekrák ellen
US9587069B2 (en) *	2012-07-23	2017-03-07	The University Of Akron	Polyisobutylene-based polyurethanes containing organically modified montmorillonite
US9067914B1 (en)	2013-12-10	2015-06-30	Genzyme Corporation	Tropomyosin-related kinase (TRK) inhibitors
TN2017000234A1 (en)	2014-12-18	2018-10-19	Genzyme Corp	Pharmaceutical formulations of tropomyosin related kinase (trk) inhibitors
MA41179A (fr)	2014-12-19	2017-10-24	Cancer Research Tech Ltd	Composés inhibiteurs de parg
US9884868B2 (en) *	2015-03-02	2018-02-06	Rigel Pharmaceuticals, Inc.	TGF-beta inhibitors
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
HRP20221196T1 (hr)	2017-10-05	2022-12-09	Fulcrum Therapeutics, Inc.	Inhibitori p38 kinaze smanjuju ekspresiju dux4 i nizvodnih gena u cilju liječenja fshd
US10899869B2 (en)	2019-01-24	2021-01-26	The University Of Akron	Glycerol containing polyurethanes and polyurethane nanocomposites
TW202112368A (zh)	2019-06-13	2021-04-01	荷蘭商法西歐知識產權股份有限公司	用於治療有關dux4表現之疾病的抑制劑組合

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX9300141A (es) *	1992-01-13	1994-07-29	Smithkline Beecham Corp	Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
DE19503806A1 (de) *	1994-02-11	1995-08-17	Bernhardt Apparatebau Gmbh Co	Vorrichtung zum Aufblasen eines Behälters oder eines Schwimmkörpers, insbesondere einer Schwimmweste
US6426360B1 (en) *	1994-07-28	2002-07-30	G D Searle & Co.	4,5-substituted imidazolyl compounds for the treatment of inflammation
US5620999A (en)	1994-07-28	1997-04-15	Weier; Richard M.	Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US5717100A (en) *	1995-10-06	1998-02-10	Merck & Co., Inc.	Substituted imidazoles having anti-cancer and cytokine inhibitory activity
WO1998007425A1 (en) *	1996-08-21	1998-02-26	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
US6087496A (en) *	1998-05-22	2000-07-11	G. D. Searle & Co.	Substituted pyrazoles suitable as p38 kinase inhibitors
US6180632B1 (en) *	1997-05-28	2001-01-30	Aventis Pharmaceuticals Products Inc.	Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
WO1999000130A1 (en)	1997-06-30	1999-01-07	Temple University - Of The Commonwealth System Of Higher Education	Method for treating vulvar vestibulitis
AR016294A1 (es) *	1997-07-02	2001-07-04	Smithkline Beecham Corp	Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
CA2314980A1 (en) *	1997-12-19	1999-07-01	Smithkline Beecham Corporation	Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
US6207687B1 (en)	1998-07-31	2001-03-27	Merck & Co., Inc.	Substituted imidazoles having cytokine inhibitory activity
US6291457B1 (en)	1999-07-01	2001-09-18	Merck & Co., Inc.	Compounds having cytokine inhibitory activity
US6608072B1 (en) *	1999-10-27	2003-08-19	Novartis Ag	Thiazole compounds and their pharmaceutical use
GB0007405D0 (en) *	2000-03-27	2000-05-17	Smithkline Beecham Corp	Compounds
BR0207990A (pt)	2001-03-09	2004-04-27	Pfizer Prod Inc	Compostos antinflamatórios de triazolopiridinas
CA2444596A1 (en)	2001-04-16	2002-10-24	Tanabe Seiyaku Co., Ltd.	Large conductance calcium-activated k channel opener
WO2003062215A1 (en)	2002-01-25	2003-07-31	Kylix Pharmaceuticals B.V.	4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
ATE323702T1 (de)	2002-08-06	2006-05-15	Astrazeneca Ab	Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
TWI332003B (en) *	2004-01-30	2010-10-21	Lilly Co Eli	Kinase inhibitors

2005
- 2005-01-11 TW TW094100682A patent/TWI332003B/zh not_active IP Right Cessation
- 2005-01-25 DK DK05704878T patent/DK1713805T3/da active
- 2005-01-25 ES ES05704878T patent/ES2326819T3/es not_active Expired - Lifetime
- 2005-01-25 AU AU2005210459A patent/AU2005210459B2/en not_active Ceased
- 2005-01-25 SI SI200530740T patent/SI1713805T1/sl unknown
- 2005-01-25 PT PT05704878T patent/PT1713805E/pt unknown
- 2005-01-25 CN CNB2005800101425A patent/CN100516064C/zh not_active Expired - Fee Related
- 2005-01-25 RU RU2006138606/04A patent/RU2348635C2/ru not_active IP Right Cessation
- 2005-01-25 AT AT05704878T patent/ATE433449T1/de active
- 2005-01-25 PL PL05704878T patent/PL1713805T3/pl unknown
- 2005-01-25 EP EP05704878A patent/EP1713805B1/en not_active Expired - Lifetime
- 2005-01-25 UA UAA200610433A patent/UA85505C2/ru unknown
- 2005-01-25 WO PCT/US2005/000025 patent/WO2005075478A1/en active Application Filing
- 2005-01-25 CA CA2559128A patent/CA2559128C/en not_active Expired - Fee Related
- 2005-01-25 NZ NZ549780A patent/NZ549780A/en not_active IP Right Cessation
- 2005-01-25 DE DE602005014848T patent/DE602005014848D1/de not_active Expired - Lifetime
- 2005-01-25 US US10/597,283 patent/US7582652B2/en not_active Expired - Fee Related
- 2005-01-26 AR ARP050100271A patent/AR047466A1/es not_active Application Discontinuation
- 2005-01-27 MY MYPI20050307A patent/MY143516A/en unknown
- 2005-01-27 DO DO2005000010A patent/DOP2005000010A/es unknown
- 2005-01-27 PE PE2005000103A patent/PE20050689A1/es not_active Application Discontinuation
- 2005-01-28 SV SV2005002001A patent/SV2006002001A/es not_active Application Discontinuation
2006
- 2006-09-12 ZA ZA200607648A patent/ZA200607648B/xx unknown
- 2006-09-14 IL IL178103A patent/IL178103A/en not_active IP Right Cessation
2007
- 2007-04-23 HK HK07104252.8A patent/HK1100141A1/xx not_active IP Right Cessation
2009
- 2009-07-14 CY CY20091100735T patent/CY1109234T1/el unknown
- 2009-07-27 US US12/509,886 patent/US20090318443A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1713805A1 (en)	2006-10-25
DOP2005000010A (es)	2005-11-15
NZ549780A (en)	2010-01-29
US20090036445A1 (en)	2009-02-05
WO2005075478A1 (en)	2005-08-18
CN1938302A (zh)	2007-03-28
CA2559128C (en)	2013-04-16
RU2006138606A (ru)	2008-05-10
ATE433449T1 (de)	2009-06-15
DE602005014848D1 (de)	2009-07-23
PL1713805T3 (pl)	2009-10-30
CA2559128A1 (en)	2005-08-18
RU2348635C2 (ru)	2009-03-10
US20090318443A1 (en)	2009-12-24
IL178103A (en)	2011-04-28
CY1109234T1 (el)	2014-07-02
TW200526660A (en)	2005-08-16
TWI332003B (en)	2010-10-21
AU2005210459B2 (en)	2010-10-21
ZA200607648B (en)	2008-06-25
PE20050689A1 (es)	2005-09-27
CN100516064C (zh)	2009-07-22
PT1713805E (pt)	2009-08-20
EP1713805B1 (en)	2009-06-10
AU2005210459A1 (en)	2005-08-18
US7582652B2 (en)	2009-09-01
SI1713805T1 (sl)	2009-10-31
ES2326819T3 (es)	2009-10-20
AR047466A1 (es)	2006-01-18
MY143516A (en)	2011-05-31
HK1100141A1 (en)	2007-09-07
UA85505C2 (en)	2009-01-26
SV2006002001A (es)	2006-02-15

Publication	Publication Date	Title
CY2021013I2 (el)	2021-12-31	Δι-αρυλ μετα-πυριμιδινο αναστολεις κινασων
DK1704145T3 (da)	2012-09-24	Selektive kinaseinhibitorer
DK1943243T3 (da)	2011-03-07	Kinase-inhibitorer
ATE520671T1 (de)	2011-09-15	Pyrimidin-harnstoff-derivate als kinase-hemmer
PT1586571E (pt)	2008-09-08	Inibidores da dipeptidil-peptidase
EP1794137A4 (en)	2009-12-02	SPECIFIC KINASE INHIBITORS
ATE505471T1 (de)	2011-04-15	Azaindol-kinaseinhibitoren
DK1979356T3 (da)	2013-11-18	Carbonylaminopyrrolopyrazoler, kraftige kinaseinhibitorer
DK2253614T3 (da)	2013-01-07	IAP-inhibitorer
DK1778718T3 (da)	2014-11-10	Iap-inhibitorer
IL177278A0 (en)	2006-12-10	Pyrazolotriazines as kinase inhibitors
IL190078A0 (en)	2008-08-07	Kinase inhibitors
EP1893607A4 (en)	2010-07-21	CHECKPOINT KINASE INHIBITORS
IL183276A0 (en)	2007-10-31	Kinase inhibitors
BRPI0716781A2 (pt)	2014-11-18	Inibidores da quinase
DE602004018837D1 (de)	2009-02-12	Ptidase-iv-inhibitoren
ITMI20041571A1 (it)	2004-10-30	Perfluoroelastomeri
HK1100141A1 (en)	2007-09-07	Kinase inhibitors
DK2013175T5 (da)	2020-12-21	p38 Map-kinase-inhibitorer
DK2035385T3 (da)	2010-03-22	Inhibitorer af akt (proteinkinase B)
ATE520664T1 (de)	2011-09-15	Tyrosinkinase-hemmer
ATE545642T1 (de)	2012-03-15	Mmp-inhibitoren
ITMI20041626A1 (it)	2004-11-06	Inibitori della chinurenina-ammino-trasferasi
BRPI0719883A2 (pt)	2015-05-05	Inibidores de quinase
DE602005008061D1 (de)	2008-08-21	Kinaseinhibitoren